Diagnostic Work up and Management of Acute Onset Vertigo
NCT05062915 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2024-09-27
Summary
Incidence: Dizziness or vertigo is a very prevalent complaint in the general population, and a common reason for seeking medical attention. In Denmark, 20-30 % have experienced dizziness/vertigo to a degree that has led to disability, sick leave, or medical contact(1). In the United States, dizziness is estimated to account for partly 2.6-4.4 million visits to emergency departments (EDs) each year, partly 4 % of main symptoms in patients admitted to EDs (2). In Germany, the estimated prevalence of dizziness is 20-30 % with an annual incidence about 11 % (3).
Terminology and definition: Dizziness or vertigo is not a disease itself but rather a symptom of various underlying disorders. Thus, vestibular, neurological, cardiovascular, metabolic, and psychiatric diseases may be associated with dizziness/vertigo as well as medical side effects. Patients (and professionals) often use the two terms dizziness and vertigo synonymously, which may cause some confusion in the choice of diagnostics. Vertigo is characteristic for vestibular disorders and is defined as sensation of self-motion when no self-motion occurs, or sensation of distorted self-motion during an otherwise normal head movement, whereas dizziness is a feeling of more general unsteadiness.
1. Is implementation of HINTS and v-HIT in an ED able to reduce the number of undiagnosed and misdiagnosed cases of acute onset vertigo as well as diagnostic delay ?
2. What are the effects of immediate and systematic balance training in case of acute vestibular diseases ?
3. What is the cost-effectiveness of implementation of HINTS and v-HIT as up front diagnostics, and systematic balance training in patients with acute vestibular diseases ?
Conditions
- Acute Vestibular Syndrome
- Vertigo
Interventions
- DIAGNOSTIC_TEST
-
HINTS
HINTS (Head Impulse, Nystagmus, test of skew) V-HIT (Head impulse test google assisted) MRI: 3-4 MRI of the brain including the posterior fossa Vestibular rehabilitation for all patients with a vestibular deficit.
Sponsors & Collaborators
-
Esbjerg Hospital - University Hospital of Southern Denmark
lead OTHER
Principal Investigators
-
Helle Agger-Nielsen, dr. · SVS - Sydvestjysk sygehus, Øre, næse og hals afdelingen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2025-07-01
- Completion
- 2025-07-01
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter
NCT02028910 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo
NCT06293989 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department
NCT02985840 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Orthostatic Hypotension in Autonomic Failure
NCT00223691 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
NCT02500732 ·Status: COMPLETED ·Phase: PHASE2
-
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms
NCT03810287 ·Status: NO_LONGER_AVAILABLE
-
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT05548270 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Sodium Bicarbonate for Acute Peripheral Vertigo
NCT05676216 ·Status: UNKNOWN ·Phase: NA
-
12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting
NCT00252993 ·Status: TERMINATED ·Phase: PHASE2
-
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
NCT03785691 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo
NCT01890538 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Oral Ondansetron Strips on Prevention of Post-Spinal Shivering
NCT07088601 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Ondansetron and the QT Interval In Adult Emergency Department Patients
NCT01759420 ·Status: COMPLETED
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
NCT05755737 ·Status: RECRUITING ·Phase: PHASE2
-
AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
NCT03908567 ·Status: COMPLETED ·Phase: PHASE2
-
Motion Sickness on Astrolabe's Vessel
NCT02911402 ·Status: COMPLETED
-
Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy
NCT01668069 ·Status: COMPLETED ·Phase: NA
-
Late Onset Postoperative Nausea and Vomiting
NCT00918190 ·Status: COMPLETED ·Phase: NA
-
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
NCT03125811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent
NCT01418157 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
NCT03865290 ·Status: RECRUITING ·Phase: PHASE2
-
Developing Individualized Strategies to Prevent Nausea and Vomiting
NCT01393288 ·Status: WITHDRAWN ·Phase: NA